highli
pathogen
influenza
virus
result
routin
season
epidem
global
pandem
continu
circul
natur
extrem
contagi
aggress
diseas
caus
rapid
system
ill
death
suscept
bird
moreov
certain
strain
subtyp
capabl
crossspeci
transmiss
thu
infect
human
high
morbid
mortal
sun
et
al
new
subtyp
emerg
accumul
antigen
shift
zhu
wang
wang
may
result
rare
influenza
viru
pandem
resist
timeli
clinic
antivir
therapi
major
problem
cure
infect
blanton
et
al
hu
et
al
inhibitor
amantadin
ramantadin
protect
host
viru
infect
amino
acid
mutat
wang
et
al
date
oseltamivir
commerci
drug
effect
human
inhibit
na
activ
howev
drugresist
strain
emerg
one
singl
amino
acid
residu
substitut
yusuf
et
al
therefor
novel
influenza
inhibitor
must
develop
virushost
interact
involv
complex
interplay
host
cellular
viral
network
discoveri
host
factor
may
regul
viral
replic
promis
approach
respect
genom
proteom
studi
provid
abund
inform
host
gene
protein
associ
viral
infect
pathogenesi
wang
et
al
zhang
et
al
mode
rnp
exit
influenza
virus
nucleu
complement
activ
export
mechan
via
nuclear
pore
complex
npc
ensur
effici
product
infecti
viru
progeni
muhlbauer
et
al
host
factor
involv
viral
replic
andor
pathogenesi
could
target
treatment
aiv
infect
without
obviou
side
effect
tradit
chines
medicin
tcm
contain
effect
compon
deal
differ
type
diseas
malaria
influenza
viru
crunkhorn
nonaka
et
al
lycorin
tcm
exhibit
acetylcholinesteraseinhibitori
butyrylcholinesteraseinhibitori
activ
wang
et
al
russia
clinic
use
expector
treat
chronic
acut
inflammatori
process
lung
bronchial
diseas
henri
et
al
past
year
lycorin
attract
great
research
interest
owe
superl
biolog
potenti
pharmacolog
action
includ
antiangiogen
antivir
antibacteri
antimalari
antiparasit
antioxid
hepatoprotect
analges
antiinflammatori
activ
inhibit
ascorb
acid
synthesi
kim
et
al
lamoralthey
et
al
cedron
et
al
giordani
et
al
citoglu
et
al
ye
et
al
wang
et
al
cembrowskalech
kepczynski
bendaif
et
al
differ
drug
may
affect
differ
molecular
pathway
may
affect
within
diseas
model
instanc
sever
studi
shown
lycorin
induc
apoptosi
suppress
propag
carcinoma
cell
li
et
al
yu
et
al
studi
demonstr
antitumor
effect
inhibit
inflammatori
factor
suppress
stat
activ
kang
et
al
although
lycorin
exhibit
wide
rang
biolog
activ
mechan
underli
effect
remain
unclear
previou
studi
efficaci
inhibitori
effect
lycorin
ec
determin
madindarbi
canin
kidney
mdck
cell
result
show
lycorin
complet
prevent
infect
indic
absenc
cytopath
effect
et
al
unlik
mechan
oseltamivir
vrnp
retain
nucleu
lycorin
treatment
instead
directli
target
viral
protein
rna
polymeras
activ
et
al
result
strongli
suggest
potenti
lycorin
antivir
agent
strain
howev
molecular
mechan
antiviralinhibitor
action
lycorin
remain
unknown
therefor
perform
compar
proteom
analysi
determin
effect
lycorin
protein
level
mdck
cell
understand
mode
action
mdck
cell
obtain
key
laboratori
veterinari
vaccin
innov
ministri
agricultur
p
r
china
mdck
cell
cultur
dulbecco
modifi
eagl
medium
dmem
invitrogen
contain
vv
fetal
bovin
serum
fb
gibco
plaqu
assay
use
determin
viral
activ
mdck
cell
et
al
three
separ
biolog
cell
cultur
made
tandem
mass
tag
tmt
proteom
experi
lycorin
fig
obtain
previous
describ
wang
et
al
experi
involv
live
influenza
viru
carri
biosafeti
facil
three
group
design
mock
group
control
v
virusinfect
group
inocul
multipl
infect
moi
h
v
remov
inocul
dmem
contain
fb
h
postinfect
hpi
l
lycorinetr
postvir
infect
group
h
adsorpt
moi
lycorin
ad
hpi
sampl
protein
dilut
sdt
buffer
contain
sd
mm
trishcl
mm
dtt
ph
follow
standard
protocol
wisniewski
et
al
homogen
heat
c
min
centrifug
g
min
room
temperatur
sampl
one
taken
quantifi
use
bicinchonin
acid
method
remain
lysat
frozen
c
use
protein
digest
conduct
use
fasp
procedur
wisniewski
et
al
brief
mg
protein
load
onto
ultrafiltr
filter
kda
cutoff
sartoriu
cell
group
harvest
underw
trypsin
digest
label
tandem
mass
tag
tmt
plex
highph
reversephas
liquid
chromatographi
use
fraction
pool
tmtlabel
peptid
mixtur
nano
liquid
chromatographymass
spectroscopi
tandem
lcmsm
analysi
raw
file
search
togeth
use
proteom
discov
quantif
data
matrix
use
statist
trend
analysi
visual
trelliscop
final
western
blot
experi
conduct
trend
verif
fullsiz
doi
goettingen
germani
contain
ua
buffer
urea
mm
trishcl
ph
centrifug
g
min
wash
ua
buffer
mm
iodoacetamid
ua
buffer
subsequ
ad
filter
block
reduc
cystein
residu
sampl
incub
min
room
temperatur
dark
centrifug
g
min
filter
wash
three
time
ua
buffer
centrifug
g
min
wash
step
next
dissolut
buffer
appli
biosystem
foster
citi
ca
usa
ad
filter
centrifug
g
min
repeat
three
time
protein
suspens
digest
trypsin
promega
madison
wi
usa
buffer
trypsin
dissolut
buffer
c
h
final
filter
unit
transfer
new
tube
dissolut
buffer
ad
follow
centrifug
g
min
result
peptid
collect
filtrat
peptid
concentr
analyz
nine
serial
sampl
subject
common
refer
sampl
includ
one
label
experi
set
shown
fig
label
strategi
avoid
potenti
miss
valu
issu
result
datadepend
msm
acquisit
zimmer
et
al
tmtlabel
peptid
subject
highph
reversedphas
fraction
seri
hplc
valu
system
agil
equip
gemininx
phenomenex
column
mm
wang
et
al
batth
francavilla
olsen
peptid
elut
flow
rate
mlmin
buffer
consist
mm
ammonium
acet
ph
buffer
b
consist
mm
ammonium
acet
vv
acetonitril
acn
ph
buffer
filter
steril
gradient
perform
separ
consist
sever
step
buffer
min
buffer
b
min
buffer
b
min
buffer
b
min
buffer
b
min
buffer
b
min
buffer
b
min
buffer
min
elut
process
monitor
measur
absorb
nm
fraction
collect
everi
min
collect
fraction
approxim
final
combin
pool
fraction
concentr
via
vacuum
centrifug
reconstitut
vv
formic
acid
sampl
store
c
lcmsm
analysi
label
sampl
analyz
use
easynlc
nanoflow
hplc
system
connect
thermo
scientif
tm
orbitrap
fusion
tm
tribrid
tm
mass
spectromet
thermo
fisher
scientif
san
jose
ca
usa
total
sampl
load
onto
thermo
scientif
easi
column
two
column
use
autosampl
flow
rate
nlmin
sequenti
separ
peptid
thermo
scientif
easi
trap
column
cm
analyt
column
cm
accomplish
use
segment
min
gradient
solvent
b
formic
acid
acn
min
follow
solvent
b
min
solvent
b
min
column
reequilibr
initi
highli
aqueou
solvent
composit
analysi
mass
spectromet
oper
posit
ion
mode
ms
spectra
acquir
rang
mz
resolv
power
ms
msm
scan
mz
fusion
set
respect
datadepend
mode
top
speed
cycl
time
ion
fragment
high
energi
collision
dissoci
maximum
ion
inject
time
set
ms
survey
scan
ms
msm
scan
automat
gain
control
target
valu
set
ms
msm
dynam
exclus
durat
raw
file
analyz
use
proteom
discover
softwar
thermo
fisher
scientif
search
fragment
spectra
perform
use
mascot
search
engin
matrix
scienc
london
uk
version
embed
proteom
discover
uniprot
canida
protein
sequenc
databas
releas
novemb
sequenc
sever
search
paramet
use
monoisotop
mass
trypsin
cleavag
enzym
two
miss
cleavag
tmt
label
cystein
carbamidomethyl
fix
modif
peptid
charg
methionin
oxid
mass
toler
set
ppm
precursor
ion
da
fragment
ion
peptid
spectral
match
filter
fals
discoveri
rate
rel
quantit
analysi
sampl
protein
base
tmt
report
ion
ratio
uniqu
peptid
repres
protein
analysi
perform
use
proteom
discover
version
rel
peak
intens
tmt
report
ion
releas
msm
spectra
use
final
ratio
obtain
rel
protein
quantif
normal
base
median
averag
protein
quantif
ratio
uniqu
peptid
obtain
confid
percentag
includ
ratio
cutoff
valu
use
identifi
upregul
downregul
protein
p
mass
spectrometri
proteom
data
deposit
proteomexchang
consortium
via
pride
partner
repositori
dataset
identifi
pxd
lycorin
access
number
proteinprotein
interact
ppi
analysi
dep
protein
string
search
tool
retriev
interact
genesprotein
version
employ
studi
potenti
ppi
analysi
dep
protein
http
stringdborg
szklarczyk
et
al
shannon
et
al
paramet
confid
score
set
yield
ppi
result
visual
cytoscap
softwar
shannon
et
al
light
blue
node
indic
upregulatedprotein
light
green
node
indic
downregulatedprotein
edg
thick
proport
combin
score
protein
bioinformat
enrich
analysi
perform
previous
describ
hui
bin
huang
cell
homogen
ice
min
ripa
buffer
cocktail
proteas
inhibitor
roch
centrifug
g
min
c
supernat
collect
store
c
western
blot
analysi
equal
amount
protein
separ
use
sdspage
subsequ
transfer
onto
polyvinyl
fluorid
membran
biorad
membran
block
bsa
incub
monoclon
antibodi
monoclon
antibodi
cell
signal
technolog
c
overnight
membran
wash
phosphatebuff
salin
incub
h
rt
goat
antirabbit
horseradish
peroxidaseconjug
secondari
antibodi
cell
signal
technolog
statist
analys
conduct
previous
describ
hui
bin
huang
zhang
li
concentr
exposur
time
lycorin
determin
avoid
cytotox
effect
host
cell
ensur
proteom
host
cell
reflect
true
respons
presenc
lycorin
prior
studi
found
assay
lycorin
toxic
cell
h
postinfect
hpi
et
al
addit
time
lycorin
addit
optim
result
show
earlier
lycorin
ad
better
effect
viral
titer
therefor
singl
replic
cycl
influenza
viru
hpi
within
lycorin
treatment
chosen
reflect
singl
viral
replic
nontox
concentr
lycorin
time
addit
assay
doseeffect
relationship
experi
show
inhibit
lycorin
aiv
becom
invalid
within
highdos
viru
jun
et
al
et
al
henc
ensur
respons
whole
cell
proteom
caus
earli
infect
activ
lycorin
effect
thu
moi
select
minimum
infecti
dose
singl
cycl
viral
infect
studi
singl
viral
replic
cycl
peschel
et
al
therefor
moi
aiv
infect
lycorin
concentr
h
incub
time
select
optim
dose
exposur
time
experi
studi
appli
tmt
method
wide
appli
quantit
proteom
cell
biolog
studi
mani
model
organ
explor
potent
antivir
agent
differ
signal
pathway
lombardi
et
al
burton
et
al
schemat
experiment
workflow
venn
diagram
vm
lv
lm
shown
fig
experi
group
consist
three
biolog
replic
n
total
protein
identifi
rel
quantifi
fdr
proteom
use
maxquant
tabl
among
statist
signific
protein
detect
anova
p
protein
abund
chang
p
discard
proteom
profil
mock
control
infect
cell
compar
vm
determin
effect
aiv
infect
mdck
cell
among
protein
group
protein
identifi
dep
determin
vm
group
proteom
profil
infect
cell
lycorinetr
infect
cell
compar
determin
effect
lycorin
treatment
infect
cell
total
protein
identifi
vl
group
dep
result
indic
wide
differ
protein
express
hpaiv
infect
lycorin
treatment
inocul
hpaiv
lycorin
result
identifi
dep
among
three
group
mdck
cell
respons
hpaiv
infect
lycorin
treatment
shown
venn
diagram
fig
proteom
profil
mdck
cell
mock
control
compar
vm
determin
effect
influenza
viru
mdck
cell
vm
group
contain
upregul
downregul
protein
vm
group
tabl
protein
network
direct
interact
intermedi
partner
ppi
level
shown
fig
gene
ontolog
analys
protein
upregul
downregul
perform
map
gene
involv
differ
cellular
process
includ
biolog
function
event
fig
larg
number
biolog
process
go
term
identifi
dep
strongli
repres
catabol
metabol
physiolog
process
infect
cell
also
assign
numer
molecular
function
bind
catalyt
molecular
transduc
activ
main
one
cellular
compon
extracellular
region
part
organel
membran
domin
go
enrich
analysi
conduct
cell
peripheri
protein
plasma
membran
protein
intrins
compon
membran
protein
molecular
transduc
activ
protein
studi
impact
dep
cell
physiolog
process
discov
intern
relat
fig
sever
identifi
protein
known
interact
one
anoth
function
biochem
pathway
therefor
kegg
pathwaybas
enrich
analysi
appli
identifi
main
pathway
potenti
affect
dep
vm
group
fig
enrich
pathway
show
protein
involv
pathway
cancer
path
extracellular
matrix
ecm
receptor
interact
path
focal
adhes
path
mitogenactiv
protein
kinas
signal
pathway
path
signal
pathway
path
data
indic
mani
chang
protein
profil
respons
influenza
viru
infect
hpi
proteom
profil
infect
cell
infect
cell
within
lycorin
treatment
compar
vl
determin
effect
lycorin
treatment
infect
cell
total
dep
found
tabl
ppi
network
perform
determin
whether
dep
interact
form
protein
complex
fig
twohundr
six
protein
least
upregul
lycorinetr
viru
control
group
found
vl
protein
significantli
downregul
go
term
dep
strongli
repres
cellular
process
singleorgan
process
biolog
regul
biolog
process
bind
catalyt
molecular
transduc
activ
molecular
function
lycorinetr
cell
also
assign
numer
cellular
compon
membraneenclos
lumen
organel
membran
domin
fig
go
enrich
analysi
show
three
main
part
nuclear
divis
protein
chromosom
segreg
protein
condens
chromosom
eight
protein
fig
function
classif
dep
conduct
kegg
enrich
analysi
protein
assign
least
one
follow
pathway
human
tlymphotrop
infect
pathway
path
cell
adhes
molecul
cam
path
epiderm
growth
factor
receptor
tyrosin
kinas
inhibitor
resist
path
janu
kinasestat
signal
pathway
path
pancreat
cancer
path
fig
result
show
differ
vm
vl
analys
gene
cochang
two
group
may
shed
light
antivir
mechan
lycorin
protein
coregul
vm
vl
select
analysi
dep
investig
annot
use
go
term
subject
go
function
analysi
tabl
fiftyfour
protein
upregul
v
group
downregul
l
group
find
indic
protein
may
particip
viral
infect
may
block
lycorin
avoid
progeni
viru
bud
seventeen
protein
downregul
v
group
induc
l
group
impli
protein
downregul
influenza
viru
infect
increas
lycorin
treatment
total
protein
show
upregul
downregul
differ
abund
heat
map
protein
obtain
fig
coupregul
codownregul
protein
analyz
go
enrich
analysi
protein
belong
least
one
term
among
upregul
protein
three
main
term
bp
categori
cellular
process
protein
metabol
process
protein
organ
substanc
metabol
process
protein
main
term
mf
categori
transcript
factor
activ
protein
nucleic
acid
bind
transcript
factor
activ
protein
main
term
cc
categori
membran
part
protein
cell
junction
protein
downregul
protein
main
term
bp
categori
local
protein
immun
system
process
protein
reproduct
protein
main
term
mf
categori
structur
molecul
activ
protein
bind
protein
main
term
cc
categori
extracellular
region
protein
membran
part
protein
fig
analysi
suggest
biolog
function
may
affect
treatment
aivinfect
mdck
cell
lycorin
addit
pathway
analysi
show
protein
involv
viral
replicationrel
pathway
instanc
oligoadenyl
cyclas
serinethreonin
protein
kinas
protein
involv
adenosin
guanin
triphosphatas
atp
gtp
activityrel
pathway
pathway
mitochondri
translat
initi
factor
protein
particip
host
cell
respons
lycorinerel
transcript
translat
process
cellular
respons
stimulu
oxoacidrel
metabol
process
may
may
relat
antivir
properti
lycorin
accord
prior
studi
vrnp
retain
nucleu
condit
lycorin
treatment
stop
cycl
influenza
viru
lead
us
search
protein
involv
vrnp
export
pathway
et
al
sever
pathway
relev
protein
target
nuclear
export
enrich
biolog
process
categori
protein
trend
vm
vl
group
candid
protein
fortun
gene
directli
relat
nuclear
transport
upregul
contrast
low
express
level
found
lycorin
treatment
control
tabl
go
term
relat
export
materi
nucleu
mrna
trna
viral
materi
viral
transcript
tabl
given
possibl
role
viral
inhibit
muhlbauer
et
al
western
blot
assay
specif
antibodi
perform
determin
express
regul
protein
protein
level
shown
fig
trend
level
chang
infect
cell
lycorin
treatment
group
similar
chang
pattern
observ
moreov
protein
level
uninfect
cell
treat
concentr
lycorin
chang
cell
treat
lycorin
influenza
viru
infect
result
indic
express
induc
influenza
viru
infect
dramat
decreas
lycorin
treatment
concentr
exhibit
toxic
uninfect
cell
accord
tmt
result
result
aiv
infect
may
induc
complet
viral
cycl
process
protein
target
lycorin
treatment
may
partli
explain
blockag
vrnp
host
cellular
nucleu
effect
drug
hpaiv
treatment
still
worldwid
problem
arai
et
al
previou
studi
found
lycorin
exhibit
stronger
antiinfluenza
activ
oseltamivir
retain
vrnp
nucleu
et
al
henc
comprehens
descript
chang
viral
cellular
protein
aiv
infect
lycorin
treatment
base
multiplex
tmtbase
quantit
carri
interact
host
cellular
protein
lycorin
factor
nucleu
transport
two
main
research
interest
proteom
largescal
studi
molecul
known
protein
critic
build
block
host
virus
drayman
et
al
kim
et
al
kleiner
et
al
vasilijev
et
al
influenza
viru
modifi
hijack
numer
process
cell
organel
replic
cycl
de
castro
martin
et
al
also
regul
subcellular
local
protein
complex
present
studi
phenomena
observ
hpaivinfect
result
fig
tabl
conjunct
total
number
significantli
regul
protein
protein
basi
number
protein
significantli
modul
pathway
associ
protein
influenza
viru
induc
profound
respons
ecmreceptor
interact
focal
adhes
signal
pathway
kegg
pathwaybas
enrich
analysi
yek
et
al
show
major
function
modul
myxoviru
influenza
viru
resist
infect
predominantli
enrich
ecmreceptor
interact
focal
adhes
pathway
liu
et
al
show
infect
hpaiv
strain
moi
infect
much
cell
studi
thu
moi
higher
infect
dose
better
studi
one
singl
viral
replic
cycl
consid
dose
effect
effici
lycorin
infect
chose
moi
singl
cycl
therefor
suitabl
time
point
hp
must
select
harvest
virusinfect
cell
treat
lycorin
use
proteom
analysi
endocyt
cell
entri
vrnp
releas
cytoplasm
enter
nucleu
viral
mrna
synthesi
replic
occur
viral
genom
encapsul
nucleoprotein
np
associ
trimer
polymeras
complex
viral
protein
np
recogn
cytoplasm
via
npc
flatt
greber
npc
highli
conserv
protein
complex
local
nuclear
peripheri
requir
import
export
protein
rna
labad
karmodiya
sengupta
influenza
viru
could
induc
protein
pathway
use
depend
replic
genom
nucleu
export
cytoplasm
via
npc
nuclear
pore
promot
nuclear
export
newli
synthes
rnp
import
process
regul
cellular
function
facilit
viral
npc
assembl
muhlbauer
et
al
prove
virusinduc
cellular
caspas
activ
caus
widen
nuclear
pore
therebi
facilit
nucleocytoplasm
transloc
howev
focus
anoth
npc
protein
correl
import
export
pathway
influenza
viru
infect
present
studi
express
upregul
infect
h
howev
differ
npc
protein
differ
function
render
direct
comparison
result
imposs
mdck
cell
infect
exhibit
tremend
chang
level
mani
protein
pathway
interestingli
npc
protein
confirm
directli
relat
export
mrnatrna
nucleu
pay
close
attent
chang
express
lycorin
treatment
lycorin
main
constitu
lycori
radiata
bulb
exhibit
wide
rang
biolog
activ
includ
antivir
masi
et
al
antimalari
cho
et
al
antibacteri
bendaif
et
al
antiparasit
antiinflammatori
park
first
report
activ
lycorin
inhibit
termin
protein
synthesi
polioviru
infect
vrijsen
et
al
subsequ
studi
found
lycorin
exhibit
antivir
activ
toward
herp
simplex
viru
renardnozaki
et
al
lin
et
al
coronaviru
li
et
al
polioviru
hwang
et
al
west
nile
viru
dengu
yellow
fever
virus
zou
et
al
enteroviru
liu
et
al
influenza
viru
et
al
hepat
c
viru
guo
et
al
adult
zika
viru
masi
et
al
although
lycorin
compound
variou
antivir
activ
molecular
mechan
underli
effect
lycorin
still
unclear
compar
pharmacolog
activ
mechan
studi
anticanc
activ
gain
deep
insight
lamoralthey
et
al
potenti
target
lycorin
action
includ
famili
protein
hdac
stat
howev
specif
target
lycorineinduc
anticanc
effect
identifi
far
present
studi
obviou
examin
lycorin
treatment
hpaivinfect
result
fig
tabl
basi
protein
significantli
modul
pathway
associ
protein
lycorinetr
cell
induc
profound
respons
cam
egfrrel
pathway
jakstat
signal
pathway
kegg
pathwaybas
enrich
analysi
shen
et
al
authent
lycorin
directli
interact
egfr
inhibit
egfr
activ
shen
et
al
hu
et
al
jin
et
al
show
lycorin
inactiv
jakstat
signal
pathway
inhibit
prolifer
cancer
cell
furthermor
present
result
agre
specif
signal
pathway
addit
go
enrich
analysi
show
protein
involv
nuclear
divis
differ
express
upon
lycorin
administr
notabl
express
decreas
upon
lycorin
treatment
dep
coupregul
codownregul
vm
vl
group
select
candid
fig
tabl
among
candid
protein
increas
infect
decreas
lycorin
treatment
viral
infect
play
signific
downmodulatori
role
candid
protein
upregul
lycorin
howev
dep
detect
current
studi
hardli
match
determin
silac
analysi
conduct
publish
hui
bin
huang
group
result
might
due
differ
instrument
appli
databas
use
mass
spectromet
qexact
appli
silac
experi
previou
studi
wherea
fusionlumo
instrument
use
present
studi
present
found
nup
protein
inhibit
lycorin
treatment
arous
great
interest
topic
focu
followup
work
explor
lycorin
affect
nucleu
transport
analyz
protein
level
western
blot
assay
found
level
increas
hpaiv
infect
lower
lycorin
treatment
addit
level
lycorin
control
group
mock
group
lycorin
significantli
reduc
express
influenza
viru
infect
may
affect
nucleocytoplasm
transport
instead
lycorin
toxic
host
cell
npc
compos
approxim
protein
known
nucleoporin
one
major
subcomplex
npc
respons
correct
assembl
npc
sachdev
et
al
given
timeofaddit
effect
lycorin
involv
earli
step
influenza
viru
replic
asid
viru
bind
viral
rnp
activ
et
al
nucleocytoplasm
transport
integr
major
influenza
viru
explic
cycl
critic
effici
replic
influenza
viru
importantli
shuttl
specif
protein
nucleu
essenti
regul
basic
function
host
cell
function
nucleocytoplasm
transport
regul
tumor
growth
cell
cycl
apoptosi
becom
therapeut
target
cancer
gravina
et
al
hill
et
al
rosebeck
et
al
recent
data
indic
viral
genom
transport
npc
alway
smooth
sail
block
result
may
basi
host
defens
mechan
evok
intrins
antivir
respons
flatt
greber
kirli
et
al
furusawa
yamada
kawaoka
show
viral
rna
accumul
nucleu
cell
observ
suggest
involv
nuclear
export
viral
rna
viral
life
cycl
deeper
understand
aiv
rna
export
nucleu
via
npc
thu
help
develop
new
antivir
drug
lycorin
inhibitor
influenza
viru
effect
inhibit
aiv
infect
compar
proteom
analysi
reveal
treatment
lycorin
alter
express
number
protein
aivinfect
cell
find
suggest
lycorin
affect
protein
express
aivinfect
cell
among
dep
modul
vc
vl
group
candid
target
predict
collect
inhibit
viral
infect
pathway
analysi
go
kegg
pathway
analys
reveal
import
npc
compon
direct
nucleocytoplasm
transport
induc
viru
infect
sharpli
decreas
lycorin
treatment
therefor
may
serv
potenti
antivir
target
genet
manipul
howev
function
character
necessari
possibl
confirm
instanc
knockdown
knockout
experi
may
perform
protein
individu
evalu
function
effect
aiv
replic
